These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18596116)

  • 1. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
    Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers.
    Walker RJ; Weggery S; Bedford JJ; McDonald FJ; Ellis G; Leader JP
    Kidney Int; 2005 Jan; 67(1):291-4. PubMed ID: 15610254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
    Zhang Y; Peti-Peterdi J; Müller CE; Carlson NG; Baqi Y; Strasburg DL; Heiney KM; Villanueva K; Kohan DE; Kishore BK
    J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
    Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
    de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen attenuates development of lithium-induced nephrogenic diabetes insipidus in rats.
    Tingskov SJ; Hu S; Frøkiær J; Kwon TH; Wang W; Nørregaard R
    Am J Physiol Renal Physiol; 2018 May; 314(5):F1020-F1025. PubMed ID: 29357422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
    Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
    J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
    Sinke AP; Kortenoeven ML; de Groot T; Baumgarten R; Devuyst O; Wetzels JF; Loffing J; Deen PM
    Am J Physiol Renal Physiol; 2014 Mar; 306(5):F525-33. PubMed ID: 24352504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial nephrogenic diabetes insipidus associated with lithium therapy.
    Nandoshvili E; Hyer S; Johri N
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31494590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
    Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
    BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus.
    Lin Y; Zhang T; Feng P; Qiu M; Liu Q; Li S; Zheng P; Kong Y; Levi M; Li C; Wang W
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F914-F925. PubMed ID: 28228402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
    de Groot T; Sinke AP; Kortenoeven ML; Alsady M; Baumgarten R; Devuyst O; Loffing J; Wetzels JF; Deen PM
    J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy.
    Batlle DC; von Riotte AB; Gaviria M; Grupp M
    N Engl J Med; 1985 Feb; 312(7):408-14. PubMed ID: 3969096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
    Boone M; Kortenoeven M; Robben JH; Deen PM
    Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla.
    Marples D; Christensen S; Christensen EI; Ottosen PD; Nielsen S
    J Clin Invest; 1995 Apr; 95(4):1838-45. PubMed ID: 7535800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.
    Sohara E; Rai T; Yang SS; Uchida K; Nitta K; Horita S; Ohno M; Harada A; Sasaki S; Uchida S
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14217-22. PubMed ID: 16968783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
    Petrillo F; Chernyakov D; Esteva-Font C; Poulsen SB; Edemir B; Fenton RA
    FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin-linked kinase regulates tubular aquaporin-2 content and intracellular location: a link between the extracellular matrix and water reabsorption.
    Cano-Peñalver JL; Griera M; Serrano I; Rodríguez-Puyol D; Dedhar S; de Frutos S; Rodríguez-Puyol M
    FASEB J; 2014 Aug; 28(8):3645-59. PubMed ID: 24784577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.
    Shi PP; Cao XR; Qu J; Volk KA; Kirby P; Williamson RA; Stokes JB; Yang B
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1334-44. PubMed ID: 17229678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil for the Treatment of Congenital Nephrogenic Diabetes Insipidus.
    Assadi F; Sharbaf FG
    Am J Nephrol; 2015; 42(1):65-9. PubMed ID: 26337818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.